Kim, S.-S.; Harford, J.B.; Moghe, M.; Doherty, C.; Chang, E.H.
A Novel P53 Nanomedicine Reduces Immunosuppression and Augments Anti-PD-1 Therapy for Non-Small Cell Lung Cancer in Syngeneic Mouse Models. Cells 2022, 11, 3434.
https://doi.org/10.3390/cells11213434
AMA Style
Kim S-S, Harford JB, Moghe M, Doherty C, Chang EH.
A Novel P53 Nanomedicine Reduces Immunosuppression and Augments Anti-PD-1 Therapy for Non-Small Cell Lung Cancer in Syngeneic Mouse Models. Cells. 2022; 11(21):3434.
https://doi.org/10.3390/cells11213434
Chicago/Turabian Style
Kim, Sang-Soo, Joe B. Harford, Manish Moghe, Caroline Doherty, and Esther H. Chang.
2022. "A Novel P53 Nanomedicine Reduces Immunosuppression and Augments Anti-PD-1 Therapy for Non-Small Cell Lung Cancer in Syngeneic Mouse Models" Cells 11, no. 21: 3434.
https://doi.org/10.3390/cells11213434
APA Style
Kim, S.-S., Harford, J. B., Moghe, M., Doherty, C., & Chang, E. H.
(2022). A Novel P53 Nanomedicine Reduces Immunosuppression and Augments Anti-PD-1 Therapy for Non-Small Cell Lung Cancer in Syngeneic Mouse Models. Cells, 11(21), 3434.
https://doi.org/10.3390/cells11213434